APA (7th ed.) Citation

Taza, G., Ahmed, N., & Vaughn, J. L. (2026). JAK Inhibitors in the Treatment of T-Cell Lymphomas: Current Evidence and Future Directions. Cancers, 18(5), 799. https://doi.org/10.3390/cancers18050799

Chicago Style (17th ed.) Citation

Taza, Gardenia, Naveed Ahmed, and John L. Vaughn. "JAK Inhibitors in the Treatment of T-Cell Lymphomas: Current Evidence and Future Directions." Cancers 18, no. 5 (2026): 799. https://doi.org/10.3390/cancers18050799.

MLA (9th ed.) Citation

Taza, Gardenia, et al. "JAK Inhibitors in the Treatment of T-Cell Lymphomas: Current Evidence and Future Directions." Cancers, vol. 18, no. 5, 2026, p. 799, https://doi.org/10.3390/cancers18050799.